How The Redwire (RDW) Investment Narrative Is Shifting With New Analyst Views And Contracts

Simply Wall St

Tue, February 24, 2026 at 7:12 AM GMT+9 3 min read

In this article:

RDW

+1.63%

TFC

-4.26%

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Redwire’s updated fair value price target now sits at US$13.11, a slight reset from US$13.22. That small move comes alongside fresh analyst research, where more constructive views are being weighed against concerns about near term catalysts, valuation, and execution risk. As you read on, you will see how to interpret these shifting calls and track the evolving Redwire story for yourself.

Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value Redwire.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

Truist lifted its Redwire price target to US$13 from US$8 and kept a Hold rating, which signals that its analysts see enough progress to justify a higher valuation, even if they are not ready to move to a more aggressive stance.

Truist points to a broadly bullish view on Aerospace & Defense for 2026, citing rising aircraft production and sustained aftermarket demand. They describe this as a supportive backdrop for companies like Redwire.

The firm also highlights ongoing recapitalization and replenishment needs in defense, along with geopolitical tensions. These are cited as reasons why demand for defense tech exposure may remain in focus for investors.

🐻 Bearish Takeaways

Despite the higher US$13 price target, Truist maintains only a Hold rating. This reflects caution around elevated valuations, especially for small and mid cap defense tech names, a group that includes Redwire.

Truist notes that defense may have fewer clear catalysts ahead. This can make stock selection more sensitive to execution risk, contract timing, and how investors feel about paying up for growth in the sector.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!

NYSE:RDW 1-Year Stock Price Chart

We’ve flagged 3 risks for Redwire. See which could impact your investment.

What’s in the News

Redwire secured a place on the Missile Defense Agency's SHIELD IDIQ contract, which has a ceiling of US$151b, with the company stating that the award does not guarantee any specific revenue.

The company is retiring the Edge Autonomy brand and regrouping its offerings into two segments: Space and Defense Tech. Both segments will operate under the Redwire name and be led by segment presidents.

Redwire completed payload integration for the European Space Agency's Syndeo 3 mission at its Belgium facility. The mission uses its Hammerhead LEO spacecraft platform and ADPMS 3 avionics ahead of a planned Q4 2026 launch from Norway.

Redwire signed an agreement with The Exploration Company to supply two IDSS compliant docking systems for TEC's Nyx spacecraft in an eight figure deal that will use Redwire's International Berthing and Docking Mechanism.

 






Story Continues  

How This Changes the Fair Value For Redwire

Fair value is set at US$13.11, adjusted from US$13.22.

Revenue growth assumption is 29.72%, revised from 31.95%.

Net profit margin assumption is 8.30%, adjusted from 8.41%.

Future P/E multiple is 61.87x, updated from 58.75x.

Discount rate is 7.79%, revised from 7.96%.

Never Miss an Update: Follow The Narrative

Narratives link a company’s story to a financial forecast and fair value, tying together growth drivers, risks, and key assumptions. They update as new contracts, guidance, and sector views come through, so you can see how the thesis evolves over time.

Head over to the Simply Wall St Community and follow the Narrative on Redwire to stay up to date on:

How expansion across defense, commercial space, and new high margin products is intended to support more diversified and recurring revenue streams.

Why acquisitions like Edge Autonomy, in-space manufacturing, and space based pharma platforms such as SpaceMD and PIL BOX sit at the center of the long term growth story.

Key risks around government contract timing, exposure to large fixed price projects, acquisition related costs, and unproven royalty and drug development models in microgravity.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include RDW.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info